Results 91 to 100 of about 2,252,550 (207)

Splenic abscesses as a first manifestation of Crohn’s disease: a case report

open access: yesBMC Gastroenterology, 2019
Background Splenic nodules are uncommon entities that occur rarely in the general population. Although an infectious etiology (primarily bacteria, followed by mycobacteria) is usually found, noninfectious diseases, including malignancies and autoimmune ...
D. F. Bavaro   +6 more
doaj   +1 more source

Charge‐Reversed Lipid Nanoparticles Enable Encapsulation of Pt2L4 Nanocages for In vivo Anti‐Cancer Treatment

open access: yesAdvanced Materials, EarlyView.
Charge‐reversed lipid nanoparticles (revLNPs) enable efficient encapsulation and delivery of cationic Pt2L4 nanocages. Encapsulation preserves potent anticancer activity while improving circulation, reducing vascular leakage, and promoting favorable biodistribution in vivo.
Renzo A. Knol   +16 more
wiley   +1 more source

Leiomyosarcoma of the Splenic Vein

open access: yes, 2013
Leiomyosarcomas arising from the wall of blood vessels are rare and aggressive neoplasm. We report a case of a previously healthy 66-year-old woman who presented with intermittent abdominal pain, progressive constipation, and weight loss.
Nicolas Gallastegui   +4 more
core   +1 more source

A Critical Review on the Evolution of Chitosan‐Based Injectable Hydrogels in Bone Regeneration

open access: yesAdvanced Materials Interfaces, EarlyView.
The graphical illustration depicts hydrogel formulation using chitosan and biocompatible cross‐linkers, major advantages, and incorporation of cells, osteoinductive factors, and therapeutic drugs. Following injection, pH‐responsive gelation enables controlled drug release, promotes cell recruitment and osteogenic differentiation, enhances extracellular
Shivani Santosh Sakhrani   +2 more
wiley   +1 more source

Organ-preserving treatment of splenomegaly in portal hypertension: clinical outcomes 12 months after partial embolization of the splenic artery

open access: yesУкраїнський журнал клінічної хірургії
Objective. To evaluate the hematological effects and clinical efficacy of partial splenic artery embolization in the treatment of splenomegaly and hypersplenism in patients with portal hypertension caused by chronic liver diseases.
S. M. Kozlov, V. A. Kondratiuk
doaj   +1 more source

Isolated Splenic Vein Thrombosis: An Unusual Cause and Review of the Literature

open access: yesCanadian Journal of Gastroenterology, 2004
Isolated obstruction (mainly due to thrombosis) of the splenic vein usually results in left-sided portal hypertension and isolated fundal varice formation. This syndrome is a rare cause of gastrointestinal bleeding. Pancreatic diseases are among the most
Seyfettin Köklü   +6 more
doaj   +1 more source

A Case of Splenic Tuberculosis

open access: yes, 1995
Splenic tuberculosis is an uncommonly considered diagnosis in clinical practice. We report a patient with splenic tuberculosis who was admitted to the hospital because offever, anorexia and weight loss.
김준명
core  

Magnetic Micro‐ and Nanorobots for Precision Thrombolysis: Design Strategies and Translational Challenges

open access: yesAdvanced Robotics Research, EarlyView.
Micro‐ and nanorobots for targeted thrombolysis. This perspective elaborates on the clinical indication of blood clot disorders and current limitations for treatment. As a novel, alternative solution, micro‐ and nanorobots can be used to treat and break down thrombi.
Joshua M. Mesfin   +3 more
wiley   +1 more source

Metabolic Changes Following Splenic Transplantation in a Case of Gaucher’s Disease

open access: yes, 1972
The fact that the highest activity of glucocerebrosidase is normally found in the spleen (2) has suggested the possibility of splenic transplantation as a means of enzyme replacement in Gaucher’s disease (1).
Carl G. Groth   +11 more
core   +1 more source

Intelligent Micro/Nanorobots for Targeted Interventional Therapy: From Bench to Clinic

open access: yesAdvanced Robotics Research, EarlyView.
Zirui Zhang et al. reviewed the application and challenges of mobile nanomachines in interventional therapy. By converting exogenous energy, including chemical, magnetic, optical, and ultrasonic sources, into mechanical forces, micro/nanorobots (MNRs) enable precise actuation at unprecedented scales. Evolving far beyond traditional drug delivery, these
Zirui Zhang   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy